Skip to content

Impact of gut hormone and inflammatory adipokines in obese patients underwent two kinds of bariatric surgery

Impact of gut hormone and inflammatory adipokines in obese patients underwent two kinds of bariatric surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-ION-16009806
Enrollment
Unknown
Registered
2016-11-09
Start date
2015-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity and metabolic related diseases

Interventions

Laparoscopic gastric bypass group:Laparoscopic gastric bypass
Laparoscopic sleeve gastrectomy group:Laparoscopic sleeve gastrectomy

Sponsors

The First Affiliated Hospital of Jinan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. According to the standard of obesity Obesity Task Force established in 2001, BMI=28k / m2 with obesity-related metabolic diseases in patients, or BMI=35kg / m2 in patients with severe obesity were selected; 2. Aged 20 to 60 years; 3. self-capacity, non-drug dependence, psychological illness; 4. not prompted stomach ulcers, erosions, tumors, polyps, atrophic gastritis and other stomach diseases in the preoperative endoscopy; 5. no history of stomach and abdominal surgery; 6. Case Source: First Affiliated Hospital of Jinan University, by the same team of doctors performed the surgical procedure.

Exclusion criteria

Exclusion criteria: All individuals that do not comply with the inclusion criteria

Design outcomes

Primary

MeasureTime frame
routine blood;serum biochemical;serum glycosylated hemoglobin;fasting blood glucose;C peptide;HP antibody;depth of gastric pits;thickness of gastric fundus gland;thickness of gastric submucosal layer;thickness of gastric submucosal layer;thickness of gastric mucosa;the number of gastric mucous cells;the number of primary cells;the number of parietal cells;diameter and number of fat cells in adipose tissue;Ghrelin;Petide YY;Glucagon-like peptide 2 (GLP2);Glucagon-like peptide 1 (GLP1);Glucagon (GC);Gastric inhibitory peptide (GIP);INSULIN;Adiponectin;Leptin;TNF-a;NLR pyrin domain containing 3;Interleukin-1ß (IL-1ß);Interleukin-6 (IL-6);Interleukin-18 (IL-18);C-reactive protein (CRP);Lipopolysaccharide;toll-like receptor 4 (TLR4);The depth of the pits between small intestine villi;

Countries

China

Contacts

Public ContactJingge Yang

The First Affiliated Hospital of Jinan University

dukeyjg@126.com+86 13560099502

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026